
Please try another search
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Vilhelm Robert Wessman | 53 | 2015 | Chairman |
Thariswan Tiensawat | - | 2024 | Representative Director |
Arni Hardarson | 58 | 2024 | Representative Director |
Chuan-Fen Wang | - | 2023 | Independent Dierctor |
Nat Ativitavas | 50 | 2023 | Representative Director |
Krisana Winitthumkul | - | 2022 | Director |
Yves Hermes | - | 2022 | Director |
Yumin Yang | - | 2024 | Independent Director |
Oranee Tangphao-Daniels | - | 2022 | Director |
Karl Alexius Tiger Karlsson | 51 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review